Identification and verification of a pathogenic MLH1 mutation c.1145dupA in a Lynch syndrome family
Abstract
Keywords
Full Text:
PDFReferences
Aarnio M. Clinicopathological features and management of cancers in Lynch syndrome. Patholog Res Int 2012; 12: 1–6. doi: 10.1155/2012/350309.
Adachi M, Banno K, Yanokura M, Iida M, Nakamura K, et al. Risk-reducing surgery in hereditary gynecological cancer: Clinical applications in Lynch syndrome and hereditary breast and ovarian cancer. Mol Clin Oncol. 2015; 3(2): 267–273. doi: 10.3892/mco.2014.460.
Allory Y. (French) [Classification and natural history of bladder tumors]. Rev Prat 2014; 64: 1365–1366, 1368–1371.
Amjad AI, Singhi AD, Balaban EP, Dudley B, Brand RE, et al. First reported case of a squamous cell carcinoma arising in the duodenum in a patient with Lynch syndrome. Int J Clin Exp Pathol 2014; 7(12): 8988–8995.
Baiocchi GL, Portolani N, Vermi W, Baronchelli C, Gheza F, et al. Lynch syndrome from a surgeon perspective: Retrospective study of clinical impact of mismatch repair protein expression analysis in colorectal cancer patients less than 50 years old. BMC Surg 2014; 14: 9. doi: 10.1186/1471-2482-14-9.
Balaguer F. Hereditary and familial colorectal cancer. Gastroenterol Hepatol 2014; 37 (Suppl 3): 77–84. doi: 10.1016/S0210-5705(14)70086-X.
Becker AE, Hernandez YG, Frucht H, Lucas AL. Pancreatic ductal adenocarcinoma: Risk factors, screening, and early detection. World J Gastroenterol 2014; 20(32): 11182–11198. doi: 10.3748/wjg.v20.i32.11182.
Buza N, Ziai J, Hui P. Mismatch repair deficiency testing in clinical practice. Expert Rev Mol Diagn 2016; 16(5): 591–604. doi: 10.1586/14737159.2016.1156533.
Kastrinos F, Stoffel EM. History, genetics, and strategies for cancer prevention in Lynch syndrome. Clin Gastroenterol Hepatol 2014; 12(5): 715–727. doi: 10.1016/j.cgh.2013.06.031.
Lu KH, Daniels M. Endometrial and ovarian cancer in women with Lynch syndrome: Update in screening and prevention. Fam Cancer 2013; 12(2): 273–277. doi: 10.1007/s10689-013-9664-5.
Sehgal R, Sheahan K, O’Connell PR, Hanly AM, Martin ST, et al. Lynch syndrome: An updated review. Genes 2014; 5(3): 497–507. doi: 10.3390/genes5030497.
Al-Sukhni W, Aronson M, Gallinger S. Hereditary colorectal cancer syndromes: Familial adenomatous polyposis and lynch syndrome. Surg Clin North Am 2008; 88(4): 819–844. doi: 10.1016/j.suc.2008.04.012.
Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group. Recommendations from the EGAPP Working Group: Genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genet Med 2009; 11(1): 35–41. doi: 10.1097/GIM.0b013e31818fa2ff.
Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med 2003; 348(10): 919–932. doi: 10.1056/NEJMra012242.
Sjursen W, McPhillips M, Scott RJ, Talseth-Palmer BA. Lynch syndrome mutation spectrum in New South Wales, Australia, including 55 novel mutations. Mol Genet Genomic Med 2016; 4(2): 223–231. doi: 10.1002/mgg3.198.
Kadyrov FA, Dzantiev L, Constantin N, Modrich P. Endonucleolytic function of MutLα in human mismatch repair. Cell 2006; 126(2): 297–308. doi: 10.1016/j.cell.2006.05.039.
Prolla TA, Pang Q, Alani E, Kolodner RD, Liskay RM. MLH1, PMS1, and MSH2 interactions during the initiation of DNA mismatch repair in yeast. Science 1994; 265(5175): 1091–1093. doi: 10.1126/science.8066446.
Bronner CE, Baker SM, Morrison PT, Warren G, Smith LG, et al. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 1994; 368(6468): 258–261. doi: 10.1038/368258a0.
Papadopoulos N, Nicolaides NC, Wei YF, Ruben SM, Carter KC, et al. Mutation of a mutL homolog in hereditary colon cancer. Science. 1994; 263(5153): 1625–1629. doi: 10.1126/science.8128251.
Thompson BA, Spurdle AB, Plazzer JP, Greenblatt MS, Akagi K, et al. Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database. Nat Genet 2014; 46(2): 107–115. doi: 10.1038/ng.2854.
Hardt K, Heick SB, Betz B, Goecke T, Yazdanparast H, et al. Missense variants in hMLH1 identified in patients from the German HNPCC consortium and functional studies. Fam Cancer 2011; 10(2): 273–284. doi: 10.1007/s10689-011-9431-4.
Richards S, Aziz N, Bale S, Bick D, Das S, et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015; 17(5): 405–423. doi: 10.1038/gim.2015.30.
Vasen HF, Mecklin JP, Khan PM, Lynch HT. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 1991; 34(5): 424–425.
Fields S, Song O. A novel genetic system to detect protein–protein interactions. Nature 1989; 340(6230): 245–246. doi: 10.1038/340245a0.
Guerrette S, Acharya S, Fishel R. The interaction of the human MutL homologues in hereditary nonpolyposis colon cancer. J Biol Chem 1999; 274(10): 6336-6341. doi: 10.1074/jbc.274.10.6336.
Nystrom-Lahti M, Perrera C, Raschle M, Panyushkina-Seiler E, Marra G, et al. Functional analysis of MLH1 mutations linked to hereditary nonpolyposis colon cancer. Genes Chromosomes Cancer 2002; 33(2): 160–167. doi: 10.1002/gcc.1225.
Kondo E, Suzuki H, Horii A, Fukushige S. A yeast two-hybrid assay provides a simple way to evaluate the vast majority of hMLH1 germ-line mutations. Cancer Res 2003; 63(12): 3302–3308.
DOI: http://dx.doi.org/10.30564/amor.v3i3.124
Refbacks
- There are currently no refbacks.
Copyright (c) 2018 Huang Feifei, Tao Xiang, Jiang Wei, Chen Jun, Feng Weiwei

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.